These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 1624025

  • 1. Efficacy of a low-dose leuprolide acetate depot in the treatment of uterine leiomyomata in Japanese women.
    Watanabe Y, Nakamura G, Matsuguchi H, Nozaki M, Sano M, Nakano H.
    Fertil Steril; 1992 Jul; 58(1):66-71. PubMed ID: 1624025
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double blind, placebo-controlled, crossover trial.
    Carr BR, Marshburn PB, Weatherall PT, Bradshaw KD, Breslau NA, Byrd W, Roark M, Steinkampf MP.
    J Clin Endocrinol Metab; 1993 May; 76(5):1217-23. PubMed ID: 8496313
    [Abstract] [Full Text] [Related]

  • 6. A prospective, randomized trial of gonadotropin-releasing hormone agonist plus estrogen-progestin or progestin "add-back" regimens for women with leiomyomata uteri.
    Friedman AJ, Daly M, Juneau-Norcross M, Rein MS, Fine C, Gleason R, Leboff M.
    J Clin Endocrinol Metab; 1993 Jun; 76(6):1439-45. PubMed ID: 8501148
    [Abstract] [Full Text] [Related]

  • 7. A randomized, placebo-controlled, double-blind study evaluating the efficacy of leuprolide acetate depot in the treatment of uterine leiomyomata.
    Friedman AJ, Harrison-Atlas D, Barbieri RL, Benacerraf B, Gleason R, Schiff I.
    Fertil Steril; 1989 Feb; 51(2):251-6. PubMed ID: 2492232
    [Abstract] [Full Text] [Related]

  • 8. Randomized double-blind study evaluating the efficacy on uterine fibroids shrinkage and on intra-operative blood loss of different length of leuprolide acetate depot treatment before myomectomy.
    Jasonni VM, D'Anna R, Mancuso A, Caruso C, Corrado F, Leonardi I.
    Acta Obstet Gynecol Scand; 2001 Oct; 80(10):956-8. PubMed ID: 11580742
    [Abstract] [Full Text] [Related]

  • 9. Experience with leuprorelin acetate depot in the treatment of fibroids: a German multicentre study.
    Cirkel U, Ochs H, Schneider HP, Mettler L, Mayer-Eichberger D, Schindler AE, Bühler K, Winkler U, Zahradnik HP, Künzig HJ.
    Clin Ther; 1992 Oct; 14 Suppl A():37-50. PubMed ID: 1606593
    [Abstract] [Full Text] [Related]

  • 10. Treatment of leiomyomata uteri with leuprolide acetate depot: a double-blind, placebo-controlled, multicenter study. The Leuprolide Study Group.
    Friedman AJ, Hoffman DI, Comite F, Browneller RW, Miller JD.
    Obstet Gynecol; 1991 May; 77(5):720-5. PubMed ID: 1901638
    [Abstract] [Full Text] [Related]

  • 11. The hemodynamic effect of GnRH agonist therapy on uterine leiomyoma vascularity: a prospective study using transvaginal color Doppler sonography.
    Aleem FA, Predanic M.
    Gynecol Endocrinol; 1995 Sep; 9(3):253-8. PubMed ID: 8540296
    [Abstract] [Full Text] [Related]

  • 12. Treatment of leiomyomata with intranasal or subcutaneous leuprolide, a gonadotropin-releasing hormone agonist.
    Friedman AJ, Barbieri RL, Benacerraf BR, Schiff I.
    Fertil Steril; 1987 Oct; 48(4):560-4. PubMed ID: 3115833
    [Abstract] [Full Text] [Related]

  • 13. Serum luteinizing hormone rises within minutes after depot leuprolide injection: implications for monitoring therapy.
    Bhatia S, Neely EK, Wilson DM.
    Pediatrics; 2002 Feb; 109(2):E30. PubMed ID: 11826240
    [Abstract] [Full Text] [Related]

  • 14. A placebo-controlled trial of a depot gonadotropin-releasing hormone analogue (leuprolide) in the treatment of uterine leiomyomata.
    Schlaff WD, Zerhouni EA, Huth JA, Chen J, Damewood MD, Rock JA.
    Obstet Gynecol; 1989 Dec; 74(6):856-62. PubMed ID: 2511532
    [Abstract] [Full Text] [Related]

  • 15. A randomized, placebo-controlled, double-blind study evaluating leuprolide acetate depot treatment before myomectomy.
    Friedman AJ, Rein MS, Harrison-Atlas D, Garfield JM, Doubilet PM.
    Fertil Steril; 1989 Nov; 52(5):728-33. PubMed ID: 2509250
    [Abstract] [Full Text] [Related]

  • 16. Regression of uterine leiomyomata in response to the antiprogesterone RU 486.
    Murphy AA, Kettel LM, Morales AJ, Roberts VJ, Yen SS.
    J Clin Endocrinol Metab; 1993 Feb; 76(2):513-7. PubMed ID: 8432797
    [Abstract] [Full Text] [Related]

  • 17. Predictors of uterine volume reduction in women with myomas treated with a gonadotropin-releasing hormone agonist.
    Friedman AJ, Daly M, Juneau-Norcross M, Rein MS.
    Fertil Steril; 1992 Aug; 58(2):413-5. PubMed ID: 1633911
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.